Project on allergic rhinitis in children with nasal septum deviation
"ASSOCIATION BETWEEN NASAL SEPTUM DEVIATION AND ALLERGIC RHINITIS IN PEDIATRIC AGE: The ARHINASD (Allergic Rhinitis in Pediatric Subjects With Nasal Septum Deviation) Project"
Federico II University · NCT06139185
This study looks at how allergic rhinitis affects children aged 6 to 14 who have a bent nasal septum to see how these conditions impact their daily lives.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 69 (estimated) |
| Ages | 6 Years to 14 Years |
| Sex | All |
| Sponsor | Federico II University (other) |
| Locations | 2 sites (Naples and 1 other locations) |
| Trial ID | NCT06139185 on ClinicalTrials.gov |
What this trial studies
This project focuses on understanding allergic rhinitis, a common inflammatory condition affecting children aged 6 to 14 years, particularly those with nasal septum deviation. The study aims to collect data on the prevalence and impact of allergic rhinitis in this demographic, given that a significant percentage of these patients experience overlapping symptoms due to nasal septum deformities. By analyzing the relationship between allergic rhinitis and nasal septum deviation, the project seeks to enhance the understanding of these conditions and their effects on quality of life.
Who should consider this trial
Good fit: Ideal candidates for this project are Caucasian children aged 6 to 14 years who have been diagnosed with allergic rhinitis.
Not a fit: Patients outside the specified age range, non-Caucasian individuals, or those with significant comorbidities may not benefit from this project.
Why it matters
Potential benefit: If successful, this project could lead to improved management strategies for allergic rhinitis in children, enhancing their quality of life.
How similar studies have performed: While the specific approach of this project may be novel, previous studies have indicated a strong correlation between allergic rhinitis and nasal septum deviation, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Caucasian ethnicity * both sexes * age between 6 and 14 years * written informed consent. Exclusion Criteria: * Non-Caucasian ethnicity * Age \<6 and \>14 years Concomitant presence of: * chronic diseases * malignancies * immunodeficiency * chronic infections * autoimmune diseases * chronic inflammatory intestinal diseases * celiac disease * genetic diseases * metabolic diseases * cystic fibrosis * chronic pulmonary diseases * malformations of the cardiovascular system * malformations of the respiratory system * malformations of the gastrointestinal system * neuropsychiatric disorders * neurological diseases * obesity * eosinophilic diseases * antibiotics use in the last 7 days * cortisone use in the last 7 days * antihistamines use in the last 7 days
Where this trial is running
Naples and 1 other locations
- Department of Traslational Medical Science - University of Naples Federico II — Naples, Italy (RECRUITING)
- University of Naples Federico II — Naples, Italy (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Rhinitis, Allergic